SG, O., G, P., J, Z., W, B., F, M., J, T., . . . AT, C. (2026). Cancer Incidence and Mortality With Aspirin in Older Adults: Follow-Up of the ASPREE Trial. JAMA oncology, 12(3), 285. https://doi.org/10.1001/jamaoncol.2025.6196
Chicago Style (17th ed.) CitationSG, Orchard, et al. "Cancer Incidence and Mortality With Aspirin in Older Adults: Follow-Up of the ASPREE Trial." JAMA Oncology 12, no. 3 (2026): 285. https://doi.org/10.1001/jamaoncol.2025.6196.
MLA (9th ed.) CitationSG, Orchard, et al. "Cancer Incidence and Mortality With Aspirin in Older Adults: Follow-Up of the ASPREE Trial." JAMA Oncology, vol. 12, no. 3, 2026, p. 285, https://doi.org/10.1001/jamaoncol.2025.6196.
Warning: These citations may not always be 100% accurate.